{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:16:24Z","timestamp":1786659384141,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10072-017-3056-9","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T07:12:41Z","timestamp":1500448361000},"page":"1799-1804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson\u2019s disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Jin-Sung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghwi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Woo","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4765-7352","authenticated-orcid":false,"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"3056_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jns.12099","volume":"19","author":"A Vital","year":"2014","unstructured":"Vital A, Lepreux S, Vital C (2014) Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum. J Peripher Nerv Syst 19:333\u2013342","journal-title":"J Peripher Nerv Syst"},{"key":"3056_CR2","first-page":"973","volume":"68","author":"A Gondeim Fde","year":"2014","unstructured":"Gondeim Fde A, de Oliveira GR, Peixoto AA Jr, Horta WG (2014) A case series of peripheral neuropathy in patients with Parkinson\u2019s disease. Ann Neurol 68:973\u2013975","journal-title":"Ann Neurol"},{"key":"3056_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jns5.12056","volume":"19","author":"A Vital","year":"2014","unstructured":"Vital A, Meissner WG, Canron MH, Martin-Negrier ML, Bezard E, Tison F et al (2014) Intra-axonal protein aggregation in the peripheral nervous system. J Peripher Nerv Syst 19:44\u201349","journal-title":"J Peripher Nerv Syst"},{"key":"3056_CR4","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","volume":"23","author":"C Toth","year":"2008","unstructured":"Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D (2008) Neuropathy as a potential complication of levodopa use in Parkinson\u2019s disease. Mov Disord 23:1850\u20131859","journal-title":"Mov Disord"},{"key":"3056_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","volume":"68","author":"C Toth","year":"2010","unstructured":"Toth C, Breithaupt K, Ge S, Duan Y, Terris JM, Thiessen A et al (2010) Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 68:28\u201336","journal-title":"Ann Neurol"},{"key":"3056_CR6","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Martey J (2011) Neuropathy in Parkinson disease: prevalence and determinants. Neurology 77:1947\u20131950","journal-title":"Neurology"},{"key":"3056_CR7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","volume":"28","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M et al (2013) Neuropathy and levodopa in Parkinson\u2019s disease: evidence from a multicenter study. Mov Disord 28:1391\u20131397","journal-title":"Mov Disord"},{"key":"3056_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.01.007","volume":"11","author":"P Valkovic","year":"2005","unstructured":"Valkovic P, Benetin J, Blazicek P, Valkovicova L, Gmitterova K, Kukumberg P (2005) Reduced plasma homocysteine levels in levodopa\/entacapone treated Parkinson patients. Parkinsonism Relat Disord 11:253\u2013256","journal-title":"Parkinsonism Relat Disord"},{"key":"3056_CR9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","volume":"25","author":"V Bril","year":"2002","unstructured":"Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25:2048\u20132052","journal-title":"Diabetes Care"},{"key":"3056_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1085-9489.2006.00078.x","volume":"11","author":"G Cavaletti","year":"2006","unstructured":"Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C et al (2006) Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst 11:135\u2013141","journal-title":"J Peripher Nerv Syst"},{"key":"3056_CR11","first-page":"15","volume":"30","author":"DJ Yun","year":"2012","unstructured":"Yun DJ, Oh J, Kim BJ, Lim JG, Bae JS, Jeong D et al (2012) Development of Korean neuropathic pain questionnaire for neuropathic pain screening and grading: a pilot study. J Korean Neurol Assoc 30:15\u201325","journal-title":"J Korean Neurol Assoc"},{"key":"3056_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneur.61.5.657","volume":"61","author":"T Muller","year":"2004","unstructured":"Muller T, Renger K, Kuhn W (2004) Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Arch Neurol 61:657\u2013660","journal-title":"Arch Neurol"},{"key":"3056_CR13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/mds.23342","volume":"25","author":"PP Urban","year":"2010","unstructured":"Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K et al (2010) Subacute axonal neuropathy in Parkinson\u2019s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 25:1748\u20131752","journal-title":"Mov Disord"},{"key":"3056_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12106","volume":"128","author":"XW Hu","year":"2013","unstructured":"Hu XW, Qin SM, Li D, Hu LF, Liu CF (2013) Elevated homocysteine levels in levodopa-treated idiopathic Parkinson\u2019s disease: a meta-analysis. Acta Neurol Scand 128:73\u201382","journal-title":"Acta Neurol Scand"},{"key":"3056_CR15","doi-asserted-by":"publisher","unstructured":"Podgorny P, Toth C (2014) Parkinson\u2019s disease and peripheral neuropathy. In: Rana AQ (ed) A synopsis of Parkinson\u2019s disease. InTech. doi:\n10.5772\/57106","DOI":"10.5772\/57106"},{"key":"3056_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/028134302317282761","volume":"20","author":"AM Hvas","year":"2002","unstructured":"Hvas AM, Lous J, Ellegaard J, Nexo E (2002) Use of plasma methlymalonic acid in diagnosing vitamin B012 deficiency in general practice. Scan J Prim Health Care 20:57\u201359","journal-title":"Scan J Prim Health Care"},{"key":"3056_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/eci.12034","volume":"43","author":"W Hermann","year":"2013","unstructured":"Hermann W, Obeid R, Herrmann W (2013) Utility and limitations of biochemical markers of vitamin B12 deficiency. Eur J Clin Investig 43:231\u2013237","journal-title":"Eur J Clin Investig"},{"key":"3056_CR18","doi-asserted-by":"publisher","unstructured":"Ulrich A, Muller D, Linnebank M, Tarnutzer AA (2015) Pitfalls in the diagnostic evaluation of subacute combined degeneration. BMJ Case Rep 2015. doi:\n10.1136\/bcr-2014-208622","DOI":"10.1136\/bcr-2014-208622"},{"key":"3056_CR19","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.4076\/1757-1626-2-6944","volume":"2","author":"F Makdsi","year":"2009","unstructured":"Makdsi F, Kadrie T (2009) Sub-acute combined degeneration with an initially normal level of vitamin B12: case report. Cases J 2:6944","journal-title":"Cases J"},{"key":"3056_CR20","doi-asserted-by":"crossref","first-page":"47388","DOI":"10.1074\/jbc.M308861200","volume":"278","author":"S Kolker","year":"2003","unstructured":"Kolker S, Schwab M, Horster F, Sauer S, Hinz A, Wolf NI et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388\u201347393","journal-title":"J Biol Chem"},{"key":"3056_CR21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mus.25377","volume":"54","author":"G Deviqili","year":"2016","unstructured":"Deviqili G, Rinaldo S, Lettieri C, Eleopra R (2016) Levodopa\/carbidopa intestinal gel therapy for advanced Parkinson\u2019s disease: an early toxic effect for small nerve fibers? Muscle Nerve 54:970\u2013972","journal-title":"Muscle Nerve"},{"key":"3056_CR22","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.parkreldis.2015.10.019","volume":"21","author":"L Kass-IIiyya","year":"2015","unstructured":"Kass-IIiyya L, Javed S, Dosai D, Kobylecki C, Marshall A, Petropoulos IN et al (2015) Small fiber neuropathy in Parkinson\u2019s disease: a clinical, pathological and corneal confocal microscopy study. Parkinsonism Relat Disord 21:1454\u20131460","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3056-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T03:25:09Z","timestamp":1505791509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3056-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3056-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}